Xofluza
Product Images NDC 50090-4102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xofluza (NDC 50090-4102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904102)

Label Image (Lbl500904102)
Xofluza 20 mg per tablet packaging label from A-S Medication Solutions. The label states that each tablet contains baloxavir marboxil equivalent to 20 mg of baloxavir, with a total of 40 mg per single dose (two 20 mg tablets). Storage instructions specify keeping the blister package at 60 to 77 degrees Fahrenheit. Includes NDC 50090-4102-0 and lot number information.*
FDA Label Image

Chemical Structure (Xofluza 01)

Chemical Structure (Xofluza 01)
Chemical structure of the active ingredient in Xofluza, showing multiple fused rings including fluorinated aromatic rings, sulfur, nitrogen, oxygen atoms, and several functional groups typical of the molecule's complex pharmacological design.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.